Search Results
Search results for "Dr. Stuart Maudsley"
Results found for "Dr. Stuart Maudsley"
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
New initiatives start. Additional questions are explored. Prevents Drift Before It Becomes Failure Preventing this form of biotech startup failure does not start It starts with a leadership shift. ✅ Founders must stop evaluating decisions individually and start managing or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult and start
- The Hidden Cost of Unclear Biotech Positioning
. ✅ Founders start adapting their message in real time , trying to meet expectations instead of setting Instead of starting from depth, it starts from relevance. better wording . 👉 Once positioning is decided, conversations stop revolving around explanation and start or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult and start
- The Hidden Operating Cadence That’s Actually Driving Your Biotech
Teams start planning around delays BD and investor messaging drifts Timelines become aspirational rather “we hope next year is better” → to “our cadence ensures it will be.” ✅ If you want a stronger 2025, start tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult and start
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
’t Feel Until It’s Too Late 👉 Every early-stage biotech reaches a moment where the science finally starts interesting but unready.” 3️⃣ Internal Alignment Frays When “the science” drives everything, different teams start tradeoffs, or simply feeling stuck, this session will get you unstuck, fast. 👉 Book a 1:1 consult and start
- Why Fundraising Mistakes Kill Strong Biotech Startups
They fail when the pressure of fundraising slowly starts reshaping how decisions are made , long before Decisions stop being evaluated based on long-term leverage and start being filtered through a single What helps the raise starts to matter more than what strengthens the company. 👉 In practice, biotech Scientific nuance starts to feel inconvenient. or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult and start
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
on both sides of the biotech fundraising table Why biotech fundraising breaks before diligence even starts 👉 This is where intellectual property gaps start to matter. the IP does not map cleanly to how the company plans to generate returns, the fundraising narrative starts tradeoffs, or simply feeling stuck, this session will get you unstuck — fast. 👉 Book a 1:1 consult and start
- Pharmacology Isn't What You Think—It's So Much More
. 👉 Start your journey with Terry’s foundational series Unlock "Unique Role of Pharmacology" now
- What If Your Data is Lying to You? The Calcium Assay Dilemma
If you're starting out in pharmacology, this lesson gives you the interpretive tools to ask smarter questions
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
“Companies started shutting down neuroscience and GPCR programs. But I stayed,” Sokhom said.
- From Technician to Trailblazer: How Sokhom Pin Designed His Own PhD Program While Working in Industry
But Sokhom’s journey started differently.
- How Early Strategic Decision Making Creates Alignment and Better Results
With alignment, execution starts to feel lighter, faster, and more coherent. Strong early decision-making starts with intention. 👉 Founders who take control of this phase do not or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult and start
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
the extracellular binding site of the GPCR, the protein changes into its active conformation , which starts to study therapeutic targets are fluorescent ligands , which are very useful in GPCR drug discovery, starting
- The Hidden Cost of Ambition in Biotech Leadership
Disciplined ambition starts with a simple shift in thinking. or simply feeling stuck, this session will help you get unstuck quickly. 👉 Book a 1:1 consult and start
- Advantages of Fluorescent Probes in GPCR Assays
fluorescent antagonist (CELT-327) was added to HCT116 cells (colon cancer cell line), detectable fluorescence starting for GPCR assays using Fluorescent Probes The preparation of the cellular system is the most common starting
- Research Network on Signal Transduction (ERNEST) has established an Emergency Fund for Ukrainian ...
schools and universities, research centers, governmental institutions, or private companies) Deadlines Start
- Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
study will evaluate TRV045 safety, tolerability, and PK in healthy volunteers Enrollment expected to start
- Breaking the Myth of High and Low Affinity Sites
your work efficiently ✅ Clarity that helps you move from assay to decision faster, with fewer false starts
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
Starting from a high-throughput screening hit, we describe the iterative optimization of a chemical series
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Starting from previously reported intracellular CCR2 antagonists, several tetramethylrhodamine (TAMRA
- Helix 8 in chemotactic receptors of the complement system
A comparison of microsecond MD trajectories started from active and inactive C5aR1 receptor conformations
- A broad look into the future of systemic sclerosis
The authors provide a hierarchical structure into the studies of the pathogenesis of SSc starting with
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
early and sustained statistically significant reduction of symptoms, as assessed by PANSS total score, starting
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Hence, new β3 -AR agonists are needed as starting points for drug development.
- Signaling pathways activated by sea bass gonadotropin-inhibitory hormone peptides in COS-7 cells...
for the understanding of signaling pathways activated by GnIH peptides in teleosts, and represent a starting
- TeachOpenCADD - A teaching platform for computer-aided drug design
Beyond their teaching purpose, the TeachOpenCADD material can serve as starting point for users’ project-directed
- A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9: Fluorescent Ligands ...
Starting from vercirnon, an intracellular C-C chemokine receptor type 9 (CCR9) antagonist and previous
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
the β2–β3 loop to move away from the α5 helix, disrupting an ionic lock and allowing the α5 helix to start
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
“That was kind of a signal to me that maybe I should start thinking about a PhD,” Catherine recalls.
- From Lab Logic to Leadership: How Scientific Thinking Holds Back Biotech Operations
. 👉 Book a 1:1 consult and start building the mindset your company actually needs.
- Why Opposing Processes Matter for Your Next GPCR Drug
Why Pipeline Efficiency Starts with Physiology Drug discovery doesn’t happen in a vacuum.



















